NDC 58468-0200
Lemtrada 12 mg per 1.2 mL injection, solution, concentrate
On the label: Genzyme Corporation.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Boehringer Ingelheim Pharma GmbH and Co. KG | Biberach an der Riss, Germany | Makes it, makes the active ingredient and tests it | Problems found, fixed voluntarilyJul 22, 2022 · 10 inspections |
| HVL Pharma UK Limited | Haverhill, United Kingdom | Packages it and labels it | Problems found, fixed voluntarilyNov 3, 2022 · 6 inspections |
| Sanofi-Aventis Deutschland GmbH | Frankfurt am Main, Germany | Tests it | Problems found, fixed voluntarilyMar 25, 2022 · 10 inspections, 1 with FDA action |
Product details
- Generic drug
- Alemtuzumab: every company that makes it
- Form
- injection, solution, concentrate, intravenous
- Strength
- 12 mg per 1.2 mL
- Approval
- BLA BLA103948
- On the market since
- Nov 18, 2014
- Package NDCs
58468-0200-1- Official label
- DailyMed (National Library of Medicine), updated Nov 3, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?